Overview
AGENCY SPEAKERS CONFIRMED!
DIA has a long history of working closely with Industry and Regulators to bring topics and speakers together with broad audiences in order to create stimulating and relevant discussions.
Join this Workshop to discuss the current PV landscape and partake in lively and constructive dialogue that is designed to expand your knowledge and enhance your practices in the following areas:
- Data Privacy in Pharmacovigilance
- Signaling and access policy to the EV database
- Safety reporting: concerns with use of new RSI guidance and issues that remain outstanding
- EU Clinical Trial Regulation: Implementation and Readiness
- Risk-Management Plan
The conference format is designed to stimulate dialogue and generate solutions through a series of interactive sessions and workshops. An informal setting allows for in-depth discussion in smaller groups.
Featured
Want to learn more about Pharmacovigilance Strategies Workshop? You've come to the right site!
Program Committee
-
Gaby L. Danan, MD, PhD Pharmacovigilance Expert
GLD, France -
Margaret Anne Walters Deputy EU Qualified Person for Pharmacovigilance
Merck, Sharp & Dohme Ltd, United Kingdom -
Maria Wishart Medical Director, Global Patient Safety
Astrazeneca, United Kingdom
Have an account?